Slider1_Desktop-min
Clarity™ Algorithm FDA Cleared for Pediatric Patients

Ceribell now provides coverage across the largest age range ever addressed by a seizure detection technology.

Slider2_Desktop
GROUNDBREAKING RESEARCH

SAFER-EEG TRIAL: Multi-center retrospective analysis in ICU patients shows that early use of Ceribell vs. conventional EEG is associated with:

  1. 4.1-day shorter median ICU stay
  2. 18% more patients from the Ceribell cohort had better neurological outcomes*

*Using mRS greater than or equal to 4 at discharge as an indicator of functional disability. Results with Ceribell vs. conventional EEG.

Slider3_Desktop
Available Now:
Streamlined EEG Reports

A standardized, simple and efficient tool to create detailed, easy to understand point-of-care EEG procedure notes.

Group 305-min (1)
Breaking News:

Ceribell Announces Pricing of Upsized IPO
IPO funding positions Ceribell to transform the diagnosis and management of patients with serious
neurological conditions

previous arrow
next arrow
decorative

The Next Chapter in our Fight to Improve Patient Care Starts Now

The Challenge of Non-convulsive Seizures

Non-convulsive seizures are prevalent in critically ill patients1

Time in seizure is associated with increase in mortality6


decorative

References and Citations

1. Herman, S.T., et al. (2015) J Clin Neurophysiol. 32(2):87-95
2. Laccheo, I., et al. (2015) Neurocrit Care. 22:202-211 
3. De Marchis, G.M., et al. (2016) Neurology. 86(3):253-260

4. Claassen, J., et al. (2004). Neurology. 62(10):1743-1748
5. Rudin, D., et al. (2011) Epilepsy Res. 96(1-2):140-150
6. Young, G.B., et al. (1996). Neurology, 47(1):83-89